# FDA Inspection 815026 - American Natl. Red Cross-Greater Chesapeake & Potomac Region - January 25, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/f9f96143-35cf-443e-ab91-424a8522811c/
Source feed: FDA_Inspections

> FDA Inspection 815026 for American Natl. Red Cross-Greater Chesapeake & Potomac Region on January 25, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 815026
- Company Name: American Natl. Red Cross-Greater Chesapeake & Potomac Region
- Inspection Date: 2013-01-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1180888 - 2022-09-12](https://www.globalkeysolutions.net/api/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/fb47542c-471b-405f-8bdc-f00374d4edda/)
- [FDA Inspection 1180888 - 2022-09-12](https://www.globalkeysolutions.net/api/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/adbd73ef-de97-4b11-8bd3-59475ce3cbe9/)
- [FDA Inspection 1062854 - 2018-07-26](https://www.globalkeysolutions.net/api/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/9476828a-72ae-4799-9284-989d30fcc2c0/)
- [FDA Inspection 983629 - 2016-09-01](https://www.globalkeysolutions.net/api/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/c17a166b-a8e3-4861-ba70-7c410411a434/)
- [FDA Inspection 943997 - 2015-10-01](https://www.globalkeysolutions.net/api/records/fda_inspections/american-natl-red-cross-greater-chesapeake-potomac-region/4ba1b88e-0fd0-4833-abc7-9c8e66d93ab9/)

Company: https://www.globalkeysolutions.net/companies/american-natl-red-cross-greater-chesapeake-potomac-region/aedf322a-3642-48f6-a582-7d897fc96eec

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d